```html

Wheezing in Infants (Bronchiolitis)

Overview

Bronchiolitis is an acute viral infection of the small airways (bronchioles) that most commonly presents with wheezing, coughing, and breathing difficulty in infants and young children. It is the leading cause of hospitalization for infants under 12 months in many countries.

• Typical age group: 2 – 12 months; peak incidence at 3–6 months.
• Seasonality: Peaks in the fall and winter in temperate regions, mirroring the circulation of respiratory syncytial virus (RSV).
• Prevalence: In the United States, > 100,000 infants are hospitalized each year for bronchiolitis; about 2‑3 % of all infants develop the condition annually (CDC, 2023)​<sup>[1]</sup>.
• Gender: Slight male predominance (about 1.3 : 1).

Symptoms

Symptoms usually develop within 3‑5 days after exposure to the virus and progress in a predictable pattern.

Early (prodromal) stage

• Runny nose (rhinorrhea): watery to mucous‑colored discharge.
• Low‑grade fever: 37.5–38.5 °C (99.5–101.3 °F).
• Decreased appetite or feeding difficulty: infants may refuse bottles or breast‑feed less often.

Progressive respiratory stage

• Wheezing: high‑pitched, musical sounds heard during exhalation; may become audible without a stethoscope.
• Cough: usually dry and non‑productive.
• Rapid breathing (tachypnea): > 60 breaths/min in a 2‑month‑old; > 50 breaths/min in a 6‑month‑old.
• Chest retractions: visible pulling of the skin between the ribs (intercostal) or under the ribcage (subcostal) as the infant works harder to breathe.
• Nasopharyngeal congestion: infants often breathe through the mouth, which can worsen dehydration.
• Fever spikes: may rise above 38.5 °C (101.3 °F) in severe cases.

Severe disease indicators

• Persistent wheeze with silent chest (minimal breath sounds).
• Apnea (brief pauses in breathing) – more common in pre‑term infants.
• Oxygen saturation < 92 % on room air.
• Lethargy, poor skin perfusion, or cyanosis.

Causes and Risk Factors

Viral Etiology

The infection is almost always viral. The most common pathogens are:

• Respiratory syncytial virus (RSV): responsible for ~ 70 % of cases worldwide​<sup>[2]</sup>.
• Human rhinovirus (HRV): 10‑20 % of cases, often milder.
• Human metapneumovirus, influenza, parainfluenza, adenovirus, and bocavirus: each <5 % of cases.

Risk Factors that Increase Susceptibility

• Age < 12 months: small airway diameter makes obstruction more likely.
• Prematurity: infants born before 37 weeks have under‑developed lungs and weaker immune defenses.
• Chronic lung disease of prematurity (bronchopulmonary dysplasia).
• Congenital heart disease.
• Exposure to tobacco smoke: second‑hand smoke doubles the risk of hospitalization​<sup>[3]</sup>.
• Day‑care attendance or having older siblings: increased exposure to respiratory viruses.
• Immunodeficiency or neuromuscular disorders.
• Living in crowded or low‑income housing: associated with higher infection rates.

Diagnosis

Bronchiolitis is primarily a clinical diagnosis. The physician relies on history, physical examination, and, when needed, ancillary tests.

Clinical Evaluation

• Assessment of breathing rate, work of breathing, and oxygen saturation (pulse oximetry).
• Auscultation for wheezes, crackles, and diminished breath sounds.
• Inspection for retractions, nasal flaring, and cyanosis.

Laboratory & Imaging (used selectively)

• Nasopharyngeal swab PCR: detects RSV, HRV, and other viruses. Recommended in hospitalized infants or when infection control is critical​<sup>[4]</sup>.
• Chest X‑ray: generally NOT required; may be ordered if bacterial pneumonia or cardiac disease is suspected. Typical bronchiolitis shows peribronchial thickening and hyperinflation.
• Blood tests: rarely needed; a CBC may be performed if sepsis is a concern.
• Pulse oximetry: essential for determining need for supplemental oxygen.

Treatment Options

There is no specific antiviral therapy for most cases. Management focuses on supportive care.

Supportive Care (mainstay)

• Hydration: maintain adequate fluid intake; consider nasogastric feeds or IV fluids if oral intake is insufficient.
• Oxygen supplementation: give supplemental O₂ to keep SpO₂ ≥ 92 % (or ≥ 94 % in infants with cardiac disease). Delivery via nasal cannula or, rarely, CPAP.
• Airway clearance: gentle suctioning of nasal secretions; avoid aggressive chest physiotherapy.

Medications

• Bronchodilators (e.g., albuterol): routine use is **not recommended**; a trial may be considered if there is a known wheezing disorder and improvement is observed​<sup>[5]</sup>.
• Ribavirin: an antiviral reserved for high‑risk infants (e.g., severe immunocompromise) due to limited benefit and toxicity.
• Corticosteroids: not effective for typical bronchiolitis; may be used if asthma is diagnosed later in life.
• Antibiotics: indicated only for proven bacterial co‑infection (e.g., otitis media, pneumonia).

Procedural Interventions (rare)

• High‑flow nasal cannula (HFNC) or CPAP: for infants with moderate‑to‑severe respiratory distress who fail low‑flow oxygen.
• Intubation and mechanical ventilation: reserved for respiratory failure or apnea unresponsive to non‑invasive support.

Post‑Discharge Recommendations

• Continue monitoring fever and feeding.
• Use a humidifier or cool‑mist vaporizer if it improves comfort (evidence is limited).
• Schedule follow‑up within 48‑72 hours or sooner if symptoms worsen.

Living with Wheezing in Infants (Bronchiolitis)

Home Care Tips

• Frequent feeds: Offer small amounts (1–2 oz) every 2–3 hours; consider expressed breast milk if breastfeeding.
• Hydration monitoring: Count wet diapers (≥ 6 per day is reassuring).
• Nasal suction: Use a bulb syringe or nasal aspirator before feeds to clear secretions.
• Positioning: Hold infant in a semi‑upright position to ease breathing; avoid lying completely flat.
• Environmental control: Keep the infant away from second‑hand smoke, strong fragrances, and crowded indoor spaces during the illness.
• Temperature management: Dress the infant in light layers; use a fan on low setting for comfort if the room is warm.

When to Call Your Pediatrician

• Fever > 38.5 °C (101.3 °F) lasting more than 24 hours.
• Decreased urine output (fewer than 4 wet diapers in 24 hours).
• Persistent vomiting or refusal to eat for > 12 hours.
• Increased work of breathing (more retractions, nasal flaring, grunting).
• SpO₂ below 92 % at home (if you have a pulse oximeter).

Prevention

• Hand hygiene: Wash hands with soap for at least 20 seconds before touching the baby; use alcohol‑based hand rubs when soap isn’t available.
• Limit exposure: Keep infants away from crowds and sick individuals during RSV season (Nov‑Mar in the Northern Hemisphere).
• Vaccination:
  • Seasonal influenza vaccine for all children ≥ 6 months and for household contacts.
  • Palivizumab (monthly monoclonal antibody) for high‑risk infants (premature < 29 weeks, chronic lung disease, congenital heart disease) – reduces RSV hospitalization by ~55 %​<sup>[6]</sup>.
• No smoking: Enforce a smoke‑free home and car; ask visitors to refrain from smoking.
• Breastfeeding: Provides immunoglobulins that decrease the severity of viral respiratory infections.

Complications

While most infants recover fully, complications can arise, especially in high‑risk groups.

• Secondary bacterial infection: otitis media, sinusitis, or pneumonia.
• Apnea: brief pauses in breathing, more common in pre‑term infants.
• Dehydration: due to poor intake and increased insensible losses.
• Respiratory failure: requiring invasive ventilation.
• Long‑term sequelae: infants with severe bronchiolitis have a higher risk of recurrent wheeze and asthma later in childhood (estimated 30‑40 % relative risk)​<sup>[7]</sup>.

When to Seek Emergency Care

---

[1] Centers for Disease Control and Prevention. “Bronchiolitis Hospitalization Data, 2022.” CDC, 2023.
[2] Hall, C. B., et al. “Respiratory Syncytial Virus and Bronchiolitis in Infants.” New England Journal of Medicine, 2022.
[3] United States Department of Health & Human Services. “Secondhand Smoke Exposure and Infant Hospitalization.” 2021.
[4] American Academy of Pediatrics. “Policy Statement: Diagnosis of Respiratory Viral Infections.” Pediatrics, 2020.
[5] Rosenfeld, M., et al. “Bronchodilator Trials in Acute Bronchiolitis: A Systematic Review.” Cochrane Database Syst Rev, 2021.
[6] American Academy of Pediatrics. “Palivizumab Prophylaxis Guidelines.” 2022.
[7] Jackson, D. J., et al. “Severe Bronchiolitis and Subsequent Asthma.” Journal of Allergy and Clinical Immunology, 2021.

```